| HP INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (In millions) |
| Three months ended | |||||||
| January 31, 2023 | January 31, 2022 | ||||||
| Cash flows from operating activities: | |||||||
| Net earnings | $ | 487 | $ | 1,086 | |||
| Adjustments to reconcile net earnings to net cash (used in) provided by operating activities: | |||||||
| Depreciation and amortization | 209 | 197 | |||||
| Stock-based compensation expense | 167 | 133 | |||||
| Restructuring and other charges | 141 | 68 | |||||
| Deferred taxes on earnings | (136 | ) | 5 | ||||
| Other, net | 4 | 186 | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||||
| Accounts receivable | 244 | 337 | |||||
| Inventory | 218 | (1,277 | ) | ||||
| Accounts payable | (1,712 | ) | 2,035 | ||||
| Net investment in leases | (16 | ) | (20 | ) | |||
| Taxes on earnings | 220 | (6 | ) | ||||
| Restructuring and other | (92 | ) | (99 | ) | |||
| Other assets and liabilities | 250 | (988 | ) | ||||
| Net cash (used in) provided by operating activities | (16 | ) | 1,657 | ||||
| Cash flows from investing activities: | |||||||
| Investment in property, plant and equipment, net | (192 | ) | (273 | ) | |||
| Purchases of available-for-sale securities and other investments | (4 | ) | — | ||||
| Maturities and sales of available-for-sale securities and other investments | 1 | — | |||||
| Collateral posted for derivative instruments | (240 | ) | 14 | ||||
| Payment made in connection with business acquisition, net of cash acquired | — | (21 | ) | ||||
| Net cash used in investing activities | (435 | ) | (280 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from (Payment of) short-term borrowings with original maturities less than 90 days, net | 200 | (400 | ) | ||||
| Proceeds from debt, net of issuance costs | 52 | 39 | |||||
| Payment of debt | (539 | ) | (50 | ) | |||
| Stock-based award activities and others | (79 | ) | (92 | ) | |||
| Repurchase of common stock | (100 | ) | (1,508 | ) | |||
| Cash dividends paid | (259 | ) | (271 | ) | |||
| Collateral returned for derivative instruments | (200 | ) | — | ||||
| Net cash used in financing activities | (925 | ) | (2,282 | ) | |||
| Decrease in cash, cash equivalents and restricted cash | (1,376 | ) | (905 | ) | |||
| Cash, cash equivalents and restricted cash at beginning of period | 3,145 | 4,299 | |||||
| Cash, cash equivalents and restricted cash at end of period | $ | 1,769 | $ | 3,394 | |||
